BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9679720)

  • 21. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
    Larstorp AC; Ariansen I; Gjesdal K; Olsen MH; Ibsen H; Devereux RB; Okin PM; Dahlöf B; Kjeldsen SE; Wachtell K
    Hypertension; 2012 Aug; 60(2):347-53. PubMed ID: 22753219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the effects of mibefradil and atenolol on regression of left ventricular hypertrophy in hypertensive patients.
    Höglund C; Cifkova R; Mimran A; Tenczer J; Watt A; Wilkins MR; Lindberg E
    Cardiology; 1998 May; 89(4):263-70. PubMed ID: 9643273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of diltiazem, metoprolol, enalapril and hydrochlorothiazide on frequency of ventricular premature complexes.
    Papademetriou V; Narayan P; Kokkinos P
    Am J Cardiol; 1994 Feb; 73(4):242-6. PubMed ID: 7507638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
    de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME
    Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of left ventricular mass by antihypertensive treatment does not improve exercise performance in essential hypertension.
    Fagard RH; Lijnen PJ
    J Hypertens; 1997 Mar; 15(3):309-17. PubMed ID: 9468459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteinuria in mild to moderate hypertension: results of the VA cooperative study of six antihypertensive agents and placebo. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Preston RA; Materson BJ; Reda DJ; Hamburger RJ; Williams DW; Smith MH
    Clin Nephrol; 1997 May; 47(5):310-5. PubMed ID: 9181278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of antihypertensive therapy on left ventricular mass in elderly patients.
    Schulman SP; Weiss JL; Becker LC; Gottlieb SO; Woodruff KM; Weisfeldt ML; Gerstenblith G
    N Engl J Med; 1990 May; 322(19):1350-6. PubMed ID: 2139175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of chronic antihypertensive therapy on the index of left ventricular mass in patients with essential hypertension.
    Komsuoğlu B; Ozgür O; Duman EL; Komsuoğlu SS
    Int J Cardiol; 1989 Jan; 22(1):75-81. PubMed ID: 2647645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind comparison of perindopril and captopril in hypertension. Effects on left ventricular morphology and function.
    Grandi AM; Venco A; Barzizza F; Petrucci E; Scalise F; Perani G; Marchesi E; Folino P; Finardi G
    Am J Hypertens; 1991 Jun; 4(6):516-20. PubMed ID: 1873003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
    Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.
    Zimmer J; Hawlitschek C; Rabald S; Hagendorff A; Zimmer HG; Rassler B
    Hypertens Res; 2015 Nov; 38(11):716-22. PubMed ID: 26178152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients.
    Beltman F; Heesen W; Smit A; May J; de Graeff P; Havinga T; Schuurman F; van der Veur E; Lie K; Meyboom-de Jong B
    J Hypertens Suppl; 1998 Oct; 16(6):S15-9. PubMed ID: 9856379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.